1 1860 128 RANDOMIZED CONTROLLED TRIAL OF A 12-WEEK YOGA-BASED (INCLUDING DIET) LIFESTYLE VS. DIETARY INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND CONTINUOUS RISK SCORE IN INDIAN ADULTS WITH METABOLIC SYNDROME. METABOLIC SYNDROME, A PREDIABETIC AND PRECARDIOVASCULAR PATHOLOGIC CONDITION THAT BEGINS EARLY IN LIFE, TRACKS INTO ADULTHOOD AND MAGNIFIES WITH AGE. RANDOMIZED CONTROLLED TRIALS EVALUATING EFFICACY OF YOGA-BASED LIFESTYLE VS. DIETARY INTERVENTION ON METABOLIC SYNDROME ARE LACKING. HERE, THE EFFICACY OF A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION VS. DIETARY INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND METABOLIC SYNDROME RISK SCORES HAVE BEEN ASSESSED IN INDIAN ADULTS WITH METABOLIC SYNDROME. IN THIS TWO-ARM, OPEN LABEL, PARALLEL GROUP, RANDOMIZED CONTROLLED TRIAL, 260 ADULTS (20-45 YEARS) DIAGNOSED WITH METABOLIC SYNDROME AS PER JOINT INTERIM STATEMENT, 2009 WERE RANDOMIZED TO YOGA-BASED (INCLUDING DIET) LIFESTYLE OR DIETARY INTERVENTION ALONE (N = 130, EACH) FOR 12 WEEKS. PRIMARY ENDPOINTS WERE THE 12-WEEK CHANGES IN CARDIO-METABOLIC RISK FACTORS AND METABOLIC RISK SCORES. THE SECONDARY ENDPOINTS WERE THE 12-WEEK CHANGES IN THE PROPORTION OF SUBJECTS RECOVERED FROM METABOLIC SYNDROME, DIETARY INTAKE, AND PHYSICAL ACTIVITY. INTENT-TO-TREAT ANALYSIS WAS PERFORMED INCLUDING ALL THE SUBJECTS WITH BASELINE DATA WITH IMPUTED MISSING DATA. TREATMENT X TIME INTERACTION SHOWED YOGA-BASED LIFESTYLE INTERVENTION HAD A GREATER TREATMENT EFFECT OVER DIETARY INTERVENTION BY SIGNIFICANTLY REDUCING WAIST CIRCUMFERENCE, CONTINUOUS METABOLIC SYNDROME Z-SCORE, AND DIETARY INTAKE/DAY WHILE SIGNIFICANTLY INCREASING PHYSICAL ACTIVITY. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL SHOWED A SIGNIFICANTLY GREATER REDUCTION FOLLOWING DIETARY INTERVENTION THAN YOGA-BASED LIFESTYLE INTERVENTION. A SIGNIFICANTLY GREATER PROPORTION OF SUBJECTS RECOVERED FROM METABOLIC SYNDROME IN YOGA-BASED LIFESTYLE (45.4%) VS. DIETARY INTERVENTION GROUP (32.3%). A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION IS MORE EFFICACIOUS THAN USUAL DIETARY INTERVENTION IN IMPROVING CARDIO-METABOLIC RISK FACTOR AND METABOLIC RISK SCORE IN INDIAN ADULTS WITH METABOLIC SYNDROME. 2020 2 2834 36 YOGA'S EFFECT ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION - A CONTROLLED TRIAL IN PRIMARY CARE. BACKGROUND: YOGA CAN REDUCE BLOOD PRESSURE AND HAS ALSO BEEN SUGGESTED TO REDUCE INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS FOR CARDIOVASCULAR DISEASES (CVDS). WE AIMED TO ASSESS THE BENEFIT OF TWO YOGA INTERVENTIONS ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION IN PRIMARY CARE. METHODS: ADULT PATIENTS FROM A HEALTH CARE CENTER IN SWEDEN, WITH DIAGNOSED HYPERTENSION, WERE INVITED TO UNDERGO A BASELINE CHECK AT THE HEALTH CARE CENTER. BASELINE CHECK INCLUDED STANDARDIZED BLOOD PRESSURE MEASUREMENT, BMI AND WEIGHT CIRCUMFERENCE MEASUREMENTS, BLOOD SAMPLING (HS-CRP, IL-6, FP-GLUCOSE, HBA1C, CHOLESTEROL, TG, LDL AND HDL) AND A QUESTIONNAIRE ON SELF-RATED QUALITY OF LIFE (WHOQOL-BREF). THERE WERE THREE GROUPS: 1) YOGA CLASS WITH YOGA INSTRUCTOR; 2) YOGA AT HOME; AND 3) A CONTROL GROUP. IN TOTAL, 83 PATIENTS WERE INCLUDED AND MATCHED AT THE GROUP LEVEL FOR SYSTOLIC BLOOD PRESSURE. A MAJORITY OF THE PATIENTS (92 %) WERE ON ANTIHYPERTENSIVE MEDICATION, WHICH THEY WERE REQUESTED NOT TO CHANGE DURING THE STUDY. AFTER 12 WEEKS OF INTERVENTION, THE ASSESSMENTS WERE PERFORMED AGAIN. RESULTS: WE RECORDED NO EVIDENCE THAT YOGA ALTERED INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS IN OUR STUDY POPULATION. A TOTAL OF 49 PARTICIPANTS (59 %) MET THE CRITERIA FOR METABOLIC SYNDROME. CONCLUSION: THE YOGA INTERVENTIONS PERFORMED IN OUR STUDY DID NOT AFFECT INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS ASSOCIATED WITH CVD IN THE STUDY POPULATION OF PRIMARY CARE PATIENTS WITH HYPERTENSION. FURTHER RANDOMIZED TRIALS ARE NEEDED TO ELUCIDATE THE EFFECTS OF YOGA ON CVD RISK FACTORS IN THIS PARTICULAR GROUP. TRAIL REGISTRATION: NCT01302535 , FEBRUARY 22, 2011. 2015 3 247 45 A YOGA INTERVENTION FOR TYPE 2 DIABETES RISK REDUCTION: A PILOT RANDOMIZED CONTROLLED TRIAL. BACKGROUND: TYPE 2 DIABETES IS A MAJOR HEALTH PROBLEM IN MANY COUNTRIES INCLUDING INDIA. YOGA MAY BE AN EFFECTIVE TYPE 2 DIABETES PREVENTION STRATEGY IN INDIA, PARTICULARLY GIVEN ITS CULTURAL FAMILIARITY. METHODS: THIS WAS A PARALLEL, RANDOMIZED CONTROLLED PILOT STUDY TO COLLECT FEASIBILITY AND PRELIMINARY EFFICACY DATA ON YOGA FOR DIABETES RISK FACTORS AMONG PEOPLE AT HIGH RISK OF DIABETES. PRIMARY OUTCOMES INCLUDED: CHANGES IN BMI, WAIST CIRCUMFERENCE, FASTING BLOOD GLUCOSE, POSTPRANDIAL BLOOD GLUCOSE, INSULIN, INSULIN RESISTANCE, BLOOD PRESSURE, AND CHOLESTEROL. WE ALSO LOOKED AT MEASURES OF PSYCHOLOGICAL WELL-BEING INCLUDING CHANGES IN DEPRESSION, ANXIETY, POSITIVE AND NEGATIVE AFFECT AND PERCEIVED STRESS. FORTY-ONE PARTICIPANTS WITH ELEVATED FASTING BLOOD GLUCOSE IN BANGALORE, INDIA WERE RANDOMIZED TO EITHER YOGA (N = 21) OR A WALKING CONTROL (N = 20). PARTICIPANTS WERE ASKED TO EITHER ATTEND YOGA CLASSES OR COMPLETE MONITORED WALKING 3-6 DAYS PER WEEK FOR EIGHT WEEKS. RANDOMIZATION AND ALLOCATION WAS PERFORMED USING COMPUTER-GENERATED RANDOM NUMBERS AND GROUP ASSIGNMENTS DELIVERED IN SEALED, OPAQUE ENVELOPES GENERATED BY OFF-SITE STUDY STAFF. DATA WERE ANALYZED BASED ON INTENTION TO TREAT. RESULTS: THIS STUDY WAS FEASIBLE IN TERMS OF RECRUITMENT, RETENTION AND ADHERENCE. IN ADDITION, YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER REDUCTIONS IN WEIGHT, WAIST CIRCUMFERENCE AND BMI VERSUS CONTROL (WEIGHT -0.8 +/- 2.1 VS. 1.4 +/- 3.6, P = 0.02; WAIST CIRCUMFERENCE -4.2 +/- 4.8 VS. 0.7 +/- 4.2, P < 0.01; BMI -0.2 +/- 0.8 VS. 0.6 +/- 1.6, P = 0.05). THERE WERE NO BETWEEN GROUP DIFFERENCES IN FASTING BLOOD GLUCOSE, POSTPRANDIAL BLOOD GLUCOSE, INSULIN RESISTANCE OR ANY OTHER FACTORS RELATED TO DIABETES RISK OR PSYCHOLOGICAL WELL-BEING. THERE WERE SIGNIFICANT REDUCTIONS IN SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, TOTAL CHOLESTEROL, ANXIETY, DEPRESSION, NEGATIVE AFFECT AND PERCEIVED STRESS IN BOTH THE YOGA INTERVENTION AND WALKING CONTROL OVER THE COURSE OF THE STUDY. CONCLUSION: AMONG INDIANS WITH ELEVATED FASTING BLOOD GLUCOSE, WE FOUND THAT PARTICIPATION IN AN 8-WEEK YOGA INTERVENTION WAS FEASIBLE AND RESULTED IN GREATER WEIGHT LOSS AND REDUCTION IN WAIST CIRCUMFERENCE WHEN COMPARED TO A WALKING CONTROL. YOGA OFFERS A PROMISING LIFESTYLE INTERVENTION FOR DECREASING WEIGHT-RELATED TYPE 2 DIABETES RISK FACTORS AND POTENTIALLY INCREASING PSYCHOLOGICAL WELL-BEING. TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIED NCT00090506. 2014 4 938 44 EFFECTS OF 1-YEAR YOGA ON CARDIOVASCULAR RISK FACTORS IN MIDDLE-AGED AND OLDER ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED TRIAL. BACKGROUND: METABOLIC SYNDROME (METS) IS A CLUSTERING OF CARDIOVASCULAR RISK FACTORS, WHICH IS ASSOCIATED WITH DIABETES MELLITUS AND CARDIOVASCULAR DISEASE. LIFESTYLE INTERVENTIONS APPLIED TO PEOPLE WITH METS HAS CONSIDERABLE BENEFICIAL EFFECTS ON DISEASE PREVENTIVE OUTCOMES. THIS STUDY AIMED TO EXAMINE THE EFFECTS OF 1-YEAR OF YOGA EXERCISE ON THE CARDIOVASCULAR RISK FACTORS INCLUDING CENTRAL OBESITY, HYPERTENSION, DYSLIPIDEMIA AND HYPERGLYCEMIA IN MIDDLE-AGED AND OLDER HONG KONG CHINESE ADULTS WITH METS. METHODS: ADULTS DIAGNOSED WITH METS USING NATIONAL CHOLESTEROL EDUCATION PROGRAM CRITERIA (N = 182; MEAN +/- SD AGE = 56 +/- 9.1) WERE RANDOMLY ASSIGNED TO A 1-YEAR YOGA INTERVENTION GROUP OR CONTROL GROUP. SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, WAIST CIRCUMFERENCE, FASTING PLASMA GLUCOSE, TRIGLYCERIDES, AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WERE EXAMINED AT BASELINE, MIDWAY, AND ON COMPLETION OF THE STUDY. PHYSICAL ACTIVITY LEVEL AND CALORIC INTAKE WERE ASSESSED AND INCLUDED IN THE COVARIATE ANALYSES. RESULTS: A REDUCTION OF THE NUMBER OF DIAGNOSTIC COMPONENTS FOR METS WAS FOUND TO BE ASSOCIATED WITH THE YOGA INTERVENTION. WAIST CIRCUMFERENCE WAS SIGNIFICANTLY IMPROVED AFTER THE 1-YEAR YOGA INTERVENTION. A TREND TOWARDS A DECREASE IN SYSTOLIC BLOOD PRESSURE WAS OBSERVED FOLLOWING YOGA INTERVENTION. CONCLUSION: THESE RESULTS SUGGEST THAT YOGA EXERCISE IMPROVES THE CARDIOVASCULAR RISK FACTORS INCLUDING CENTRAL OBESITY AND BLOOD PRESSURE IN MIDDLE-AGED AND OLDER ADULTS WITH METS. THESE FINDINGS SUPPORT THE COMPLEMENTARY BENEFICIAL ROLE OF YOGA IN MANAGING METS. 2015 5 926 34 EFFECTIVENESS OF YOGA LIFESTYLE ON LIPID METABOLISM IN A VULNERABLE POPULATION-A COMMUNITY BASED MULTICENTER RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DYSLIPIDEMIA POSES A HIGH RISK FOR CARDIOVASCULAR DISEASE AND STROKE IN TYPE 2 DIABETES (T2DM). THERE ARE NO STUDIES ON THE IMPACT OF A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL ON LIPID PROFILES IN A HIGH-RISK DIABETES POPULATION. METHODS: HERE, WE REPORT THE RESULTS OF LIPID PROFILE VALUES OF 11,254 (YOGA 5932 AND CONTROL 5322) ADULTS (20-70 YEARS) OF BOTH GENDERS WITH HIGH RISK (>/=60 ON INDIAN DIABETES RISK SCORE) FOR DIABETES FROM A NATIONWIDE RURAL AND URBAN COMMUNITY-BASED TWO GROUP (YOGA AND CONVENTIONAL MANAGEMENT) CLUSTER RANDOMIZED CONTROLLED TRIAL. THE YOGA GROUP PRACTICED A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL (DYP) IN NINE DAY CAMPS FOLLOWED BY DAILY ONE-HOUR PRACTICE. BIOCHEMICAL PROFILING INCLUDED GLYCATED HEMOGLOBIN AND LIPID PROFILES BEFORE AND AFTER THREE MONTHS. RESULTS: THERE WAS A SIGNIFICANT DIFFERENCE BETWEEN GROUPS (P < 0.001 ANCOVA) WITH IMPROVED SERUM TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND HIGH-DENSITY LIPOPROTEIN IN THE YOGA GROUP COMPARED TO THE CONTROL GROUP. FURTHER, THE REGULATORY EFFECT OF YOGA WAS NOTED WITH A SIGNIFICANT DECREASE OR INCREASE IN THOSE WITH HIGH OR LOW VALUES OF LIPIDS, RESPECTIVELY, WITH MARGINAL OR NO CHANGE IN THOSE WITHIN THE NORMAL RANGE. CONCLUSION: YOGA LIFESTYLE IMPROVES AND REGULATES (LOWERED IF HIGH, INCREASED IF LOW) THE BLOOD LIPID LEVELS IN BOTH GENDERS OF PREDIABETIC AND DIABETIC INDIVIDUALS IN BOTH RURAL AND URBAN INDIAN COMMUNITIES. 2021 6 1783 51 PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE IN INDIANS WITH METABOLIC SYNDROME UNDERGOING RANDOMIZED CONTROLLED TRIAL OF YOGA-BASED LIFESTYLE INTERVENTION VS DIETARY INTERVENTION. THE PRESENT STUDY EXPLORES THE EFFICACY OF 12-WEEK YOGA + DIET-BASED LIFESTYLE INTERVENTION (YBLI) VS DIETARY INTERVENTION (DI) ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND IDENTIFIES THE PREDICTORS OF CHANGE IN HRQOL IN INDIANS WITH METABOLIC SYNDROME (MET S). DATA FROM THE HISTORICAL RANDOMIZED CONTROLLED TRIAL WAS USED INCLUDING ADULTS (N = 260, 20-45 YEARS) WITH MET S. FOUR DOMAINS OF HRQOL WERE MEASURED AT BASELINE, 2 AND 12 WEEKS USING WHOQOL-BREF QUESTIONNAIRE. GENERALIZED ESTIMATING EQUATION AND CHI-SQUARE TEST WAS USED TO COMPARE 12-WEEK CHANGES IN HRQOL DOMAINS AND PROPORTION OF SUBJECTS, RESPECTIVELY. CHANGES IN HRQOL WERE PREDICTED USING REGRESSION MODELS CONCERNING CHANGES IN BODY MASS INDEX (BMI), PHYSICAL ACTIVITY, TOTAL CALORIE INTAKE, ADIPONECTIN, AND SUPEROXIDE DISMUTASE (SOD) LEVELS. EXPLORATORY MEDIATION ANALYSIS WAS CARRIED OUT USING BARON & KENNY APPROACH. YBLI RESULTED IN A SIGNIFICANTLY GREATER INCREASE IN THE PHYSICAL DOMAIN SCORE OF HRQOL THAN DI. A SIGNIFICANTLY GREATER PROPORTION OF SUBJECTS IN YBLI GROUP (71%) SHOWED AN INCREASE IN PHYSICAL DOMAIN SCORES COMPARED TO DI (51%). A UNIT CHANGE IN BMI NEGATIVELY PREDICTED A UNIT CHANGE IN PHYSICAL, PSYCHOLOGICAL AND ENVIRONMENTAL HEALTH. WHEREAS, A UNIT CHANGE IN ADIPONECTIN AND SOD LEVELS POSITIVELY PREDICTED A UNIT CHANGE IN PHYSICAL AND ENVIRONMENTAL HEALTH. PARTIAL MEDIATION BETWEEN YBLI INTERVENTION AND PHYSICAL HRQOL DOMAIN WAS OBSERVED VIA ADIPONECTIN. IN CONCLUSION, A 12-WEEK YBLI HAS A POSITIVE AND GREATER EFFECT ON HRQOL PHYSICAL DOMAIN SCORE THAN FOLLOWING DI ALONE. CHANGES IN BMI, ADIPONECTIN, AND SOD LEVELS MAY PREDICT CHANGES IN HRQOL DOMAINS AFTER LIFESTYLE INTERVENTION. 2021 7 39 30 A BRIEF BUT COMPREHENSIVE LIFESTYLE EDUCATION PROGRAM BASED ON YOGA REDUCES RISK FACTORS FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. OBJECTIVES: THE OBJECTIVE OF THE STUDY WAS TO STUDY THE SHORT-TERM IMPACT OF A BRIEF LIFESTYLE INTERVENTION BASED ON YOGA ON SOME OF THE BIOCHEMICAL INDICATORS OF RISK FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. DESIGN: THE VARIABLES OF INTEREST WERE MEASURED AT THE BEGINNING (DAY 1) AND END (DAY 10) OF THE INTERVENTION USING A PRE-POST DESIGN. SETTING: THE STUDY IS THE RESULT OF OPERATIONAL RESEARCH CARRIED OUT IN OUR INTEGRAL HEALTH CLINIC (IHC). THE IHC IS AN OUTPATIENT FACILITY WHICH CONDUCTS 8-DAY LIFESTYLE MODIFICATION PROGRAMS BASED ON YOGA FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASE. A NEW COURSE BEGINS EVERY ALTERNATE WEEK OF THE YEAR. SUBJECTS: THE STUDY IS BASED ON DATA COLLECTED ON 98 SUBJECTS (67 MALE, 31 FEMALE), AGES 20-74 YEARS, WHO ATTENDED ONE OF OUR PROGRAMS. THE SUBJECTS WERE A HETEROGENEOUS GROUP OF PATIENTS WITH HYPERTENSION, CORONARY ARTERY DISEASE, DIABETES MELLITUS, AND A VARIETY OF OTHER ILLNESSES. INTERVENTION: THE INTERVENTION CONSISTED OF ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), RELAXATION TECHNIQUES, GROUP SUPPORT, INDIVIDUALIZED ADVICE, LECTURES AND FILMS ON THE PHILOSOPHY OF YOGA AND THE PLACE OF YOGA IN DAILY LIFE, MEDITATION, STRESS MANAGEMENT, NUTRITION, AND KNOWLEDGE ABOUT THE ILLNESS. OUTCOME MEASURES: THE OUTCOME MEASURES WERE FASTING PLASMA GLUCOSE AND SERUM LIPOPROTEIN PROFILE. THESE VARIABLES WERE DETERMINED IN FASTING BLOOD SAMPLES, TAKEN ON THE FIRST AND LAST DAY OF THE COURSE. RESULTS: FASTING PLASMA GLUCOSE, SERUM TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL, VERY- LDL CHOLESTEROL, THE RATIO OF TOTAL CHOLESTEROL TO HIGH DENSITY LIPOPROTEIN (HDL) CHOLESTEROL, AND TOTAL TRIGLYCERIDES WERE SIGNIFICANTLY LOWER, AND HDL CHOLESTEROL SIGNIFICANTLY HIGHER, ON THE LAST DAY OF THE COURSE COMPARED TO THE FIRST DAY OF THE COURSE. THE CHANGES WERE MORE MARKED IN SUBJECTS WITH HYPERGLYCEMIA OR HYPERCHOLESTEROLEMIA. CONCLUSIONS: THE OBSERVATIONS SUGGEST THAT A SHORT LIFESTYLE MODIFICATION AND STRESS MANAGEMENT EDUCATION PROGRAM LEADS TO FAVORABLE METABOLIC EFFECTS WITHIN A PERIOD OF 9 DAYS. 2005 8 1902 36 RESTORATIVE YOGA IN ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED, CONTROLLED PILOT TRIAL. BACKGROUND: METABOLIC SYNDROME INCREASES THE RISK OF DIABETES AND CARDIOVASCULAR DISEASE. YOGA IMPROVES SOME METABOLIC PARAMETERS, BUT IT HAS NOT BEEN STUDIED IN PERSONS WITH METABOLIC SYNDROME. WE CONDUCTED A RANDOMIZED CONTROLLED PILOT TRIAL TO DETERMINE WHETHER A RESTORATIVE YOGA INTERVENTION WAS FEASIBLE AND ACCEPTABLE IN UNDERACTIVE, OVERWEIGHT ADULTS WITH METABOLIC SYNDROME. METHODS: TWENTY SIX UNDERACTIVE, OVERWEIGHT ADULT MEN AND WOMEN WITH METABOLIC SYNDROME WERE RANDOMIZED TO ATTEND 15 YOGA SESSIONS OF 90 MINUTES EACH OVER 10 WEEKS OR TO A WAIT-LIST CONTROL GROUP. FEASIBILITY WAS MEASURED BY RECRUITMENT RATES, SUBJECT RETENTION, AND ADHERENCE. ACCEPTABILITY WAS ASSESSED BY INTERVIEW AND QUESTIONNAIRES. CHANGES IN METABOLIC OUTCOMES AND QUESTIONNAIRE MEASURES FROM BASELINE TO WEEK 10 WERE CALCULATED. RESULTS: A TOTAL OF 280 PEOPLE WERE SCREENED BY PHONE, AND 93 WITH HIGH LIKELIHOOD OF METABOLIC SYNDROME WERE INVITED TO A SCREENING VISIT. OF THE 68 WHO ATTENDED SCREENING VISITS, 26 (38%) WERE RANDOMIZED, AND 24 (92%) COMPLETED THE TRIAL. ATTENDANCE AT YOGA CLASSES AND ADHERENCE TO HOME PRACTICE EXCEEDED OUR GOALS. IN THE YOGA GROUP, ALL PARTICIPANTS GAVE THE STUDY THE HIGHEST POSSIBLE SATISFACTION RATING, AND THE MAJORITY (87%) FELT THAT THE YOGA POSES WERE EASY TO PERFORM. THERE WAS TREND TO REDUCED BLOOD PRESSURE (P = 0.07), A SIGNIFICANT INCREASE IN ENERGY LEVEL (P < 0.009), AND TRENDS TO IMPROVEMENT IN WELL-BEING (P < 0.12) AND STRESS (P < 0.22) IN THE YOGA VERSUS CONTROL GROUP. CONCLUSIONS: RESTORATIVE YOGA WAS A FEASIBLE AND ACCEPTABLE INTERVENTION IN OVERWEIGHT ADULTS WITH METABOLIC SYNDROME. THE EFFICACY OF YOGA FOR IMPROVING METABOLIC PARAMETERS IN THIS POPULATION SHOULD BE EXPLORED IN A LARGER RANDOMIZED CONTROLLED TRIAL. 2008 9 1402 40 IMPACT OF YOGA ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION - A CONTROLLED TRIAL IN PRIMARY CARE, MATCHED FOR SYSTOLIC BLOOD PRESSURE. BACKGROUND: MEDICAL TREATMENT OF HYPERTENSION IS NOT ALWAYS SUFFICIENT TO ACHIEVE BLOOD PRESSURE CONTROL. DESPITE THIS, PREVIOUS STUDIES ON SUPPLEMENTARY THERAPIES, SUCH AS YOGA, ARE RELATIVELY FEW. WE INVESTIGATED THE EFFECTS OF TWO YOGA INTERVENTIONS ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS IN PRIMARY HEALTH CARE DIAGNOSED WITH HYPERTENSION. METHODS: ADULT PATIENTS (AGE 20-80 YEARS) WITH DIAGNOSED HYPERTENSION WERE IDENTIFIED BY AN ELECTRONIC CHART SEARCH AT A PRIMARY HEALTH CARE CENTER IN SOUTHERN SWEDEN. IN TOTAL, 83 SUBJECTS WITH BLOOD PRESSURE VALUES OF 120-179//=25 KG/M(2)) PERSONS (N = 279) AGED 20-60 YEARS. INTERVENTION: PRETESTED YOGA-BASED LIFESTYLE INTERVENTION, INCLUDING ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), RELAXATION TECHNIQUES, LECTURES, GROUP SUPPORT, NUTRITION AWARENESS PROGRAM, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: PRIMARY OUTCOME MEASURE WAS HRQOL, MEASURED BY USING SHORT VERSION OF WORLD HEALTH ORGANIZATION QUALITY OF LIFE (WHOQOL-BREF) QUESTIONNAIRE. SECONDARY OUTCOME MEASURES WERE ANTHROPOMETRIC VARIABLES, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, PULSE RATE, LIPID PROFILE, AND FASTING GLUCOSE. A SUBGROUP ANALYSIS ACCORDING TO SEX WAS ALSO PERFORMED. RESULTS: THE OVERALL QUALITY OF LIFE AND HEALTH IMPROVED AFTER SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT AND OBESE PERSONS. PHYSICAL, PSYCHOLOGICAL AND ENVIRONMENTAL DOMAIN SCORES SIGNIFICANTLY INCREASED FROM BASELINE TO DAY 10, AND EFFICACY WAS NOTED IN BOTH MALE AND FEMALE SUBGROUPS. AFTER 10 DAYS OF INTERVENTION, THE FOLLOWING ALSO DECREASED SIGNIFICANTLY: BODY WEIGHT, BMI, TOTAL BODY FAT, WAIST AND HIP CIRCUMFERENCE, WAIST-TO-HIP RATIO, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN, TRIGLYCERIDES, AND FASTING GLUCOSE. CONCLUSION: A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION HAD A POSITIVE EFFECT ON HRQOL IN OVERWEIGHT AND OBESE PERSONS. 2016 11 2353 36 UTILIZATION OF 3-MONTH YOGA PROGRAM FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES: A PILOT STUDY. VARIOUS MODES OF PHYSICAL ACTIVITY, COMBINED WITH DIETING, HAVE BEEN WIDELY RECOMMENDED TO PREVENT OR DELAY TYPE 2 DIABETES. AMONG THESE, YOGA HOLDS PROMISE FOR REDUCING RISK FACTORS FOR TYPE 2 DIABETES BY PROMOTING WEIGHT LOSS, IMPROVING GLUCOSE LEVELS AND REDUCING BLOOD PRESSURE AND LIPID LEVELS. THIS PILOT STUDY AIMED TO ASSESS THE FEASIBILITY OF IMPLEMENTING A 12-WEEK YOGA PROGRAM AMONG ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. TWENTY-THREE ADULTS (19 WHITES AND 4 NON-WHITES) WERE RANDOMLY ASSIGNED TO THE YOGA INTERVENTION GROUP OR THE EDUCATIONAL GROUP. THE YOGA GROUP PARTICIPATED IN A 3-MONTH YOGA INTERVENTION WITH SESSIONS TWICE PER WEEK AND THE EDUCATIONAL GROUP RECEIVED GENERAL HEALTH EDUCATIONAL MATERIALS EVERY 2 WEEKS. ALL PARTICIPANTS COMPLETED QUESTIONNAIRES AND HAD BLOOD TESTS AT BASELINE AND AT THE END OF 3 MONTHS. EFFECT SIZES WERE REPORTED TO SUMMARIZE THE EFFICACY OF THE INTERVENTION. ALL PARTICIPANTS ASSIGNED TO THE YOGA INTERVENTION COMPLETED THE YOGA PROGRAM WITHOUT COMPLICATION AND EXPRESSED HIGH SATISFACTION WITH THE PROGRAM (99.2%). THEIR YOGA SESSION ATTENDANCE RANGED FROM 58.3 TO 100%. COMPARED WITH THE EDUCATION GROUP, THE YOGA GROUP EXPERIENCED IMPROVEMENTS IN WEIGHT, BLOOD PRESSURE, INSULIN, TRIGLYCERIDES AND EXERCISE SELF-EFFICACY INDICATED BY SMALL TO LARGE EFFECT SIZES. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR THIS GROUP. 2011 12 685 35 EFFECT OF AN INTEGRATED NATUROPATHY AND YOGA PROGRAM ON LONG-TERM GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE COHORT STUDY. AIM: LIFESTYLE IS AN IMPORTANT RISK FACTOR FOR INCREASING THE PREVALENCE OF DIABETES IN THE INDIAN POPULATION. IN THIS STUDY, WE EVALUATE THE EFFECTS OF NATUROPATHY TREATMENT, SALT-RESTRICTED LOW-CALORIE DIETS, AND YOGA IN LONG-TERM GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. METHODS: IN THIS PROSPECTIVE, LONGITUDINAL, TWO-ARM COHORT STUDY, PATIENTS WITH TYPE 2 DIABETES MELLITUS REFERRED FROM A TERTIARY CARE CENTER UNDERGOING A 3-MONTH RESIDENTIAL NATUROPATHY TREATMENT WERE COMPARED WITH THOSE UNDERGOING ONLY CONVENTIONAL MANAGEMENT ON GLYCEMIC CONTROL. BOTH FASTING AND POSTPRANDIAL BLOOD GLUCOSE (PPBG) LEVELS WERE ASSESSED AT BASELINE, 3 MONTHS FOLLOWING INTERVENTION, AT 6 MONTHS, AND 12 MONTHS FROM THE STUDY START. DATA WERE ANALYZED USING REPEATED-MEASURES ANOVA WITH POST HOC BONFERRONI CORRECTION. RESULTS: NATUROPATHY AND YOGA INTERVENTION SIGNIFICANTLY REDUCED PPBG LEVELS (P < 0.001), GLYCATED HEMOGLOBIN LEVELS (P < 0.001), AND REDUCED REQUIREMENT FOR ANTIDIABETIC MEDICATIONS (P < 0.008) IN THE INTERVENTION GROUP COMPARED TO CONTROLS. THE EFFECTS WERE MORE PROFOUND IMMEDIATELY FOLLOWING INTERVENTION AND LASTED UP TO 6 MONTHS FROM THE START OF THE STUDY. CONCLUSION: THE RESULTS SUGGEST BENEFIT WITH AN INTENSIVE RESIDENTIAL NATUROPATHY-BASED LIFESTYLE INTERVENTION PROGRAM. RANDOMIZED CONTROLLED TRIALS ARE NEEDED TO FURTHER VALIDATE THE FINDINGS. 2020 13 1849 38 QUASI PROSPECTIVE COMPARATIVE STUDY ON EFFECT OF YOGA AMONG PREDIABETICS ON PROGRESSION OF CARDIOVASCULAR RISK FACTORS. INTRODUCTION: PREDIABETIC PATIENTS HAVE HIGHER RISK FOR CARDIOVASCULAR DISEASES, WHICH FURTHER INCREASES THE RATE OF MORTALITY. REASON FOR THE RATE OF INCREASE MAY BE LACK OF OBSERVATION, FOLLOW-UP PROGRAMS, AND SELF-AWARENESS ABOUT THE CONDITIONS OF DISEASE. LIFESTYLE INTERVENTIONS SUCH AS YOGA CAN PROVE TO BE A BENEFICIAL NONPHARMACOLOGIC INTERVENTION IN PREVENTING PROGRESSION OF PREDIABETES TO TYPE 2 DIABETES. THIS STUDY HIGHLIGHTS IMPORTANCE OF SHORT-TERM INTERVENTION, I.E., YOGA IN PREDIABETIC PATIENTS AND USE IT AS A TOOL FOR PRIMARY PREVENTION OF DIABETES. METHODS: THIS WAS AN INTERVENTIONAL STUDY AMONG ADULTS AGED 30-50 YEARS IN RUHS COLLEGE OF MEDICAL SCIENCES AND ASSOCIATED RUKMANI DEVI BENI PRASAD JAIPURIA HOSPITAL IN JAIPUR CITY. THE DESIGN OF STUDY WAS QUASI PROSPECTIVE COMPARATIVE STUDY. A TOTAL OF 102 PREDIABETIC PATIENTS OF AGE GROUP 30-50 YEARS WERE RECRUITED FROM JAIPURIA HOSPITAL. THESE WERE DIVIDED INTO TWO GROUPS: STUDY GROUP (GROUP A, N = 51) WERE ENGAGED IN YOGA SESSION AND CONTROL GROUP (B, N = 51) NOT PERFORMED ANY YOGA SESSION. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN BLOOD GLUCOSE (P < 0.001), GLYCATED HEMOGLOBIN (P < 0.01), LIPID PROFILE CHOLESTEROL (P < 0.01), TRIGLYCERIDE (P < 0.01), AND LOW-DENSITY LIPOPROTEIN (P < 0.01), BUT HIGH-DENSITY LIPOPROTEIN (P < 0.02) AND VERY LOW-DENSITY LIPOPROTEIN INCREASE (P < 0.03) BUT NOT STATISTICALLY SIGNIFICANT RELATIVE TO THE CONTROL GROUP. CONCLUSION: SHORT-TERM YOGA INTERVENTION IS HELPFUL IN THE CONTROL OF GLYCEMIC PARAMETERS LIKE BLOOD GLUCOSE, GLYCATED HEMOGLOBIN AND LIPID PROFILE IN PREDIABETIC PATIENTS. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR PREDIABETICS PERFORMING YOGA. 2019 14 1491 35 INTERLEUKIN-6, VITAMIN D & DIABETES RISK-FACTORS MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT/OBESE INDIVIDUALS. BACKGROUND & OBJECTIVES: SEVERAL DIABETES PREVENTION PROGRAMMES HAVE DEMONSTRATED A REDUCTION IN INCIDENCE OF DIABETES IN INDIVIDUALS WITH PREDIABETES THROUGH WEIGHT LOSS. SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION PROGRAMMES HAVE ALSO BEEN SHOWN TO BE EFFICACIOUS IN WEIGHT LOSS. THIS STUDY WAS UNDERTAKEN TO INVESTIGATE IF INTERLEUKIN (IL)-6, VITAMIN D, NEOPTERIN, VASPIN, AND DIABETES RISK FACTORS CAN BE MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT/OBESE SUBJECTS. METHODS: IN THIS PILOT STUDY, 34 OVERWEIGHT/OBESE [BODY MASS INDEX (BMI) >/= 23 TO <35 KG/M [2] PER ASIAN CUT-OFF VALUES] INDIVIDUALS WERE ENROLLED, AND RECEIVED DIRECTLY SUPERVISED INTERVENTION FOR 10 DAYS. THEREAFTER, THEY WERE ADVISED TO FOLLOW THIS YOGA-BASED LIFESTYLE AT HOME FOR ONE MONTH, AND WERE REASSESSED FOR STUDY VARIABLES AT DAY 30. RESULTS: THERE WAS A REDUCTION FROM BASELINE TO DAY 10 IN WEIGHT ( P <0.001), BMI ( P <0.001), WAIST/HIP-RATIO ( P <0.05), BLOOD GLUCOSE ( P <0.01), AND A SIGNIFICANT IMPROVEMENT IN LIPID PROFILE. THERE WAS A DECREASE IN MEDIAN FASTING INSULIN ( P <0.05), HOMEOSTATIC MODEL ASSESSMENT-INSULIN RESISTANCE ( P <0.01), AND IL-6 ( PP <0.05). A NON-SIGNIFICANT INCREASE IN 25-OH-VITAMIN D, AND A DECREASE IN NEOPTERIN AND VASPIN WERE OBSERVED. TWENTY SUBJECTS RETURNED FOR FOLLOW UP ASSESSMENTS. AT DAY 30, WEIGHT LOSS WAS SUSTAINED WHILE SYSTOLIC BLOOD PRESSURE ALSO SHOWED REDUCTION ( P <0.05). CHANGES IN VITAMIN D LEVELS WERE SIGNIFICANTLY AND NEGATIVELY CORRELATED WITH CHANGES IN WEIGHT, BMI AND FASTING BLOOD GLUCOSE, AND POSITIVELY WITH CHANGE IN HIGH DENSITY LIPOPROTEIN. CHANGES IN BODY WEIGHT AND BMI SIGNIFICANTLY AND POSITIVELY CORRELATED WITH INSULIN. CHANGES IN IL-6 LEVELS POSITIVELY AND SIGNIFICANTLY CORRELATED WITH CHANGE IN NEOPTERIN LEVELS. INTERPRETATION & CONCLUSIONS: THE FINDINGS SHOWED THAT IL-6, VITAMIN D, AND DIABETES RISK FACTORS WERE FAVOURABLY MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OBESITY. THIS STUDY ALSO HIGHLIGHTED THE CHALLENGES IN COMPLIANCE ASSOCIATED WITH THE FOLLOW UP OF SUBJECTS FOLLOWING AN AGGRESSIVE SUPERVISED INTERVENTION OF 10 DAYS. 2015 15 2691 38 YOGA IN WOMEN WITH ABDOMINAL OBESITYA RANDOMIZED CONTROLLED TRIAL. BACKGROUND: ABDOMINAL OBESITY IS A MAJOR RISK FACTOR FOR MORBIDITY AND MORTALITY. THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECT OF YOGA ON WAIST CIRCUMFERENCE AND OTHER ANTHROPOMETRIC AND SELF-REPORTED VARIABLES IN WOMEN WITH ABDOMINAL OBESITY. METHODS: 60 WOMEN WITH ABDOMINAL OBESITY (WAIST CIRCUMFERENCE >/= 88 CM; BODY-MASS INDEX [BMI] >/= 25) WERE RANDOMLY ALLOCATED IN A 2:1 RATIO TO EITHER A 12-WEEK YOGA INTERVENTION (N = 40) OR A WAITING LIST (N = 20). THE WAIST CIRCUMFERENCE WAS THE PRIMARY ENDPOINT. SECONDARY (EXPLORATORY) ENDPOINTS INCLUDED THE WAIST/HIP RATIO, BODY WEIGHT, BMI, BODY FAT PERCENTAGE, BODY MUSCLE MASS PERCENTAGE, BLOOD PRESSURE, HEALTH-RELATED QUALITY OF LIFE, SELF-ESTEEM, SUBJECTIVE STRESS, BODY AWARENESS, AND BODY RESPONSIVENESS, AND THE SAFETY OF THE INTERVENTION. THE PERSONS ASSESSING THE OUTCOMES WERE BLINDED TO THE GROUP TO WHICH THE PATIENTS BELONGED. RESULTS: THE PATIENTS IN THE YOGA GROUP PARTICIPATED IN A MEAN OF 30.2+/-9.2 (MAXIMUM, 42) HOURS OF SUPERVISED YOGA PRACTICE. THEIR ABDOMINAL CIRCUM - FERENCE WAS SIGNIFICANTLY REDUCED IN COMPARISON TO THE PARTICIPANTS ON THE WAITING LIST, WITH AN INTERGROUP DIFFERENCE OF -3.8 CM (95% CONFIDENCE INTERVAL [-6.1; -1,.5]; P = 0.001). THERE WERE FURTHER, MODERATE INTERGROUP DIFFERENCES IN THE WAIST/HIP RATIO, BODY WEIGHT, BMI, BODY FAT PERCENTAGE, BODY MUSCLE MASS PERCENTAGE, MENTAL AND PHYSICAL WELL-BEING, SELF-ESTEEM, SUBJECTIVE STRESS, BODY AWARENESS, AND TRUST IN BODILY SENSATIONS (ALL P<0.05). THERE WERE NO SERIOUS ADVERSE EVENTS. NONE OF THE PARTICIPANTS EMBARKED ON A LOW-CALORIE DIET WHILE PARTICIPATING IN THE STUDY. CONCLUSION: THE 12-WEEK YOGA INTERVENTION HAD MODERATELY STRONG POSITIVE EFFECTS ON ANTHROPOMETRIC AND SELF-REPORTED VARIABLES IN WOMEN WITH ABDOMINAL OBESITY. YOGA IS SAFE IN THIS POPULATION AND CAN BE RECOMMENDED AS A TECHNIQUE FOR COMBATING ABDOMINAL OBESITY IN WOMEN. 2016 16 795 35 EFFECT OF YOGA INTERVENTION IN THE MANAGEMENT OF HYPERTENSION: A PREVENTIVE TRIAL. BACKGROUND: NONCOMMUNICABLE DISEASES ARE ON THE RISE IN INDIA. HYPERTENSION IS ONE OF THE MAJOR RISK FACTORS FOR CARDIOVASCULAR DISEASES AND ALSO LABELED AS A CHRONIC LIFESTYLE DISORDER. HENCE, NON-PHARMACOLOGICAL INTERVENTIONS LEADING TO LIFESTYLE MODIFICATIONS ARE OF UTMOST IMPORTANCE TO CONTROL AND PREVENT HYPERTENSION. THIS TRIAL AIMS TO IMPLEMENT YOGA INTERVENTION TO THE EXPERIMENTAL GROUP IN ADDITION TO MEDICINES, ADVICE ON DIET AND PHYSICAL ACTIVITY AND TO COMPARE BLOOD PRESSURE AND PERCEIVED STRESS SCORES WITH THE CONTROL GROUP. METHODS: IT WAS AN OPEN-LABEL, TWO-ARMED, NON-RANDOMIZED CONTROLLED TRIAL, CONDUCTED AT A TERTIARY CARE CENTER ON 145 PATIENTS WITH HYPERTENSION: 73 IN THE INTERVENTION GROUP AND 72 IN THE CONTROL GROUP. THE INTERVENTION GROUP RECEIVED YOGA INTERVENTION FOR A PERIOD OF 4 MONTHS ON A WEEKLY BASIS ALONG WITH ADVICE ON PHYSICAL ACTIVITY, DIET, AND ROUTINE MEDICINES. THE CONTROL GROUP DID NOT RECEIVE YOGA INTERVENTION. RESULTS: THE MEAN AGE OF THE PARTICIPANTS WAS 51.3 +/- 9.4, FEMALES (58.2%) OUTNUMBERED MALES (41.3%). FOLLOWING THE INTERVENTION, PERCEIVED STRESS SCORE AND BLOOD PRESSURE SHOWED A SIGNIFICANT REDUCTION BETWEEN TWO GROUPS (P < 0.001). ALSO, PERCEIVED STRESS AND BLOOD PRESSURE WERE FOUND TO BE REDUCED SIGNIFICANTLY WITHIN BOTH GROUPS (P < 0.001). CONCLUSIONS: YOGA PROVES TO BE AN EFFECTIVE, SAFE, AND LESS EXPENSIVE ADJUNCT THERAPY FOR HYPERTENSION MANAGEMENT. YOGA WAS ALSO FOUND TO BE EFFECTIVE IN REDUCING THE LEVEL OF STRESS. DIET MODIFICATION AND PHYSICAL ACTIVITY HAVE GOT AN IMPORTANT ROLE TO PLAY IN THE CONTROL AND PREVENTION OF HYPERTENSION. 2021 17 1328 37 HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASES FOLLOWING A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION: A NON-PHARMACOLOGICAL MODULATION. OBJECTIVES: THE OBJECTIVE OF THE STUDY WAS TO ASSESS THE EFFECT OF A BRIEF BUT COMPREHENSIVE YOGA-BASED LIFESTYLE INTERVENTION ON HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C). METHODS: THIS PROSPECTIVE INTERVENTIONAL STUDY WAS PERFORMED AT THE INTEGRAL HEALTH CLINIC (IHC), AN OUTPATIENT FACILITY AT ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, A TERTIARY HEALTH CARE CENTRE, CONDUCTING YOGA-BASED LIFESTYLE INTERVENTION PROGRAMMES FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. THE STUDY INCLUDED APPARENTLY HEALTHY NORMAL WEIGHT, OVERWEIGHT AND OBESE SUBJECTS WHO UNDERWENT A PRETESTED 10-DAY YOGA-BASED PROGRAMME INCLUDING ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), MEDITATION, GROUP DISCUSSIONS, LECTURES AND INDIVIDUALIZED ADVICE ON STRESS MANAGEMENT AND HEALTHY DIET. THE PRIMARY OUTCOME MEASURE WAS CHANGE IN SERUM HDL-C AT DAY 10 VERSUS DAY 0. RESULTS: 238 PARTICIPANTS (147 WOMEN, 91 MEN, 38.81+/-11.40 YEARS) WERE INCLUDED IN THE STUDY. THERE WAS A SIGNIFICANT INCREASE IN HDL-C LEVELS FROM BASELINE TO DAY 10 (42.93+/-5.00 VS 43.52+/-5.07 MG/DL, P = 0.043). NOTABLY, HDL-C WAS SIGNIFICANTLY IMPROVED IN THOSE FOR WHOM THE BASELINE HDL-C LEVELS WERE LOWER THAN THE RECOMMENDED VALUES. ALSO, THERE WAS A REDUCTION IN BLOOD PRESSURE, FASTING BLOOD GLUCOSE, AND IMPROVEMENT IN OTHER LIPID PROFILE VARIABLES. CONCLUSION: THIS YOGA-BASED LIFESTYLE INTERVENTION SIGNIFICANTLY INCREASED HDL-C LEVELS IN A SHORT DURATION OF 10 DAYS. THIS HAS ADDITIONAL CLINICAL RELEVANCE AS HDL-C IS SUGGESTED TO BE ONE OF THE STRONGEST STATISTICALLY INDEPENDENT PREDICTORS OF MAJOR CARDIOVASCULAR EVENTS. 2014 18 944 43 EFFECTS OF A 12-WEEK HATHA YOGA INTERVENTION ON METABOLIC RISK AND QUALITY OF LIFE IN HONG KONG CHINESE ADULTS WITH AND WITHOUT METABOLIC SYNDROME. OBJECTIVE: TO DETERMINE THE EFFICACY OF A 12-WEEK HATHA YOGA INTERVENTION TO IMPROVE METABOLIC RISK PROFILES AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN CHINESE ADULTS WITH AND WITHOUT METABOLIC SYNDROME (METS). METHODS: WE CONDUCTED A CONTROLLED TRIAL WITHIN AN UNIVERSITY-AFFILIATED HOSPITAL. 173 CHINESE MEN AND WOMEN AGED 18 OR ABOVE WERE ASSIGNED TO EITHER THE YOGA INTERVENTION GROUP (N = 87) OR THE CONTROL GROUP (N = 86). PRIMARY OUTCOMES INCLUDED 12-WEEK CHANGE IN METABOLIC RISK FACTORS AND METS Z SCORE. SECONDARY OUTCOME WAS HRQOL (MEDICAL OUTCOMES SHORT FORM SURVEY AT 12 WEEKS). RESULTS: THE MEAN AGE OF PARTICIPANTS WAS 52.0 (SD 7.4, RANGE 31-71) YEARS. ANALYSIS INVOLVING THE ENTIRE STUDY POPULATION REVEALED THAT THE YOGA GROUP ACHIEVED GREATER DECLINE IN WAIST CIRCUMFERENCE (P<0.001), FASTING GLUCOSE (P<0.01), TRIGLYCERIDES (P<0.05), AND METS Z SCORE (P<0.01). YOGA TRAINING ALSO IMPROVED GENERAL HEALTH PERCEPTIONS (P<0.01), PHYSICAL COMPONENT SCORE (P<0.01), AND SOCIAL FUNCTIONING (P<0.01) DOMAINS SCORE OF HRQOL. HOWEVER, NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED IN THE MEAN CHANGE OF SYSTOLIC/DIASTOLIC BLOOD PRESSURES OR HIGH-DENSITY LIPID PROTEIN CHOLESTEROL (ALL P>0.05). THERE WERE NO SIGNIFICANT DIFFERENCES IN THE INTERVENTION EFFECTS ON WAIST CIRCUMFERENCE AND METS Z SCORE BETWEEN THE METS SUBGROUPS (BOTH P>0.05). CONCLUSION: A 12-WEEK HATHA YOGA INTERVENTION IMPROVES METABOLIC RISK PROFILES AND HRQOL IN CHINESE ADULTS WITH AND WITHOUT METS. TRIAL REGISTRATION: AUSTRALIAN NEW ZEALAND CLINICAL TRIALS REGISTRY ACTRN12613000816752. 2015 19 662 22 EFFECT OF 3-MONTH YOGA ON OXIDATIVE STRESS IN TYPE 2 DIABETES WITH OR WITHOUT COMPLICATIONS: A CONTROLLED CLINICAL TRIAL. OBJECTIVE: TO ASSESS THE EFFECT OF YOGA ON ANTHROPOMETRY, BLOOD PRESSURE, GLYCEMIC CONTROL, AND OXIDATIVE STRESS IN TYPE 2 DIABETIC PATIENTS ON STANDARD CARE IN COMPARISON WITH STANDARD CARE ALONE. RESEARCH DESIGN AND METHODS: THE STUDY INVOLVED 123 PATIENTS STRATIFIED ACCORDING TO GROUPS WITH MICROVASCULAR COMPLICATIONS, MACROVASCULAR COMPLICATIONS, AND PERIPHERAL NEUROPATHY AND WITHOUT COMPLICATIONS AND ASSIGNED TO RECEIVE EITHER STANDARD CARE OR STANDARD CARE ALONG WITH ADDITIONAL YOGA FOR 3 MONTHS. RESULTS: IN COMPARISON WITH STANDARD CARE ALONE, YOGA RESULTED IN SIGNIFICANT REDUCTION IN BMI, GLYCEMIC CONTROL, AND MALONDIALDEHYDE AND INCREASE IN GLUTATHIONE AND VITAMIN C. THERE WERE NO DIFFERENCES IN WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO, BLOOD PRESSURE, VITAMIN E, OR SUPEROXIDE DISMUTASE IN THE YOGA GROUP AT FOLLOW-UP. CONCLUSIONS: YOGA CAN BE USED AS AN EFFECTIVE THERAPY IN REDUCING OXIDATIVE STRESS IN TYPE 2 DIABETES. YOGA IN ADDITION TO STANDARD CARE HELPS REDUCE BMI AND IMPROVE GLYCEMIC CONTROL IN TYPE 2 DIABETIC PATIENTS. 2011 20 1552 33 LIFESTYLE MODIFICATION IN BLOOD PRESSURE STUDY II (LIMBS): STUDY PROTOCOL OF A RANDOMIZED CONTROLLED TRIAL ASSESSING THE EFFICACY OF A 24 WEEK STRUCTURED YOGA PROGRAM VERSUS LIFESTYLE MODIFICATION ON BLOOD PRESSURE REDUCTION. HYPERTENSION IS A MAJOR PUBLIC HEALTH ISSUE AFFECTING 68 MILLION ADULTS IN THE UNITED STATES. LIFESTYLE MODIFICATIONS INCLUDING COMPLEMENTARY THERAPIES SUCH AS THE MOVEMENT BASED MIND BODY PRACTICE OF YOGA HAVE BECOME INCREASINGLY POPULAR IN THE UNITED STATES AND HAVE BEEN CONSIDERED AS A POTENTIAL ALTERNATIVE TO MEDICATION IN BLOOD PRESSURE REDUCTION. WE COMPLETED A PILOT STUDY IN 2009 WHICH SHOWED MEANINGFUL DECREASES IN 24-HOUR AMBULATORY BLOOD PRESSURE READINGS AFTER A 12 WEEK PERIOD OF YOGA PARTICIPATION. BASED ON DATA FROM OUR PILOT STUDY WE ARE NOW COMPLETING THE LIFESTYLE MODIFICATION AND BLOOD PRESSURE STUDY (LIMBS II) WHICH IS A PHASE 2 RANDOMIZED CONTROLLED TRIAL DESIGNED TO DETERMINE THE EFFECTS OF YOGA THERAPY AND ENHANCED LIFESTYLE MODIFICATION ON LOWERING BLOOD PRESSURE IN PRE-HYPERTENSIVE AND STAGE 1 HYPERTENSIVE SUBJECTS. USING 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING, LIMBS II AIMS TO COMPARE THE EFFECTS ON BLOOD PRESSURE REDUCTION IN SUBJECTS RANDOMIZED FOR 24 WEEKS TO ONE OF THE THREE FOLLOWING GROUPS: YOGA THERAPY VERSUS BLOOD PRESSURE EDUCATION PROGRAM (SODIUM RESTRICTION AND WALKING PROGRAM) VERSUS A COMBINATION PROGRAM THAT INVOLVES COMPONENTS OF BOTH GROUPS. LIMBS II WILL ALSO EXAMINE THE IMPACT THAT CHANGES IN BLOOD PRESSURE HAVE ON CEREBRAL BLOOD FLOW. IF SUCCESSFUL, THE LIMBS STUDY WILL DETERMINE IF YOGA THERAPY COMBINED WITH ENHANCED LIFESTYLE MODIFICATION WILL RESULT IN CLINICALLY MEANINGFUL DECREASES IN BLOOD PRESSURE AND THUS CAN BE IMPLEMENTED AS AN ALTERNATIVE TO DRUG THERAPY FOR PATIENTS WITH PREHYPERTENSION AND STAGE 1 HYPERTENSION. 2013